Real-World Data Presented by Evoke Pharma and EVERSANA at
Patients treated with Gimoti® (metoclopramide) nasal spray showed statistically significant fewer emergency department visits, inpatient hospitalizations,...
Source: globenewswire.com
Mattd Onofrio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mattd Onofrio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mattd Onofrio Today - Breaking & Trending Today
United States Patent and Trademark Office (USPTO) Grants
The Company Will Submit for FDA Orange-Book Listing in the Near Term...
Source: globenewswire.com
Evoke Pharma, Inc.: Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
SOLANA BEACH, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an
Source: finanznachrichten.de
Evoke Pharma Announces Approval of GIMOTI® to Florida State Medicaid Program
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Evoke Pharma Announces Approval of GIMOTI to Florida State Medicaid Program
15.06.2022 - SOLANA BEACH, Calif., June 15, 2022 (GLOBE NEWSWIRE) - Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal ... Seite 1
Source: wallstreet-online.de